TrialJournal of the International AIDS Society2025

No significant drug-drug interaction between oral TAF-based PrEP and feminizing hormone therapy among transgender women in Thailand: the iFACT-3 study.

Akarin Hiransuthikul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.